Yi‐Lan Weng

533 total citations
8 papers, 54 citations indexed

About

Yi‐Lan Weng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi‐Lan Weng has authored 8 papers receiving a total of 54 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Yi‐Lan Weng's work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Research and Splicing (3 papers). Yi‐Lan Weng is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Research and Splicing (3 papers). Yi‐Lan Weng collaborates with scholars based in United States, China and United Kingdom. Yi‐Lan Weng's co-authors include Shuang Li, Guo‐li Ming, Gavin W. Britz, Chao Cheng, Hongjun Song, Wenhao Chen, Zhaoqian Liu, Dawei Zou, Yanding Zhao and Evelien Schaafsma and has published in prestigious journals such as Molecular Cell, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Yi‐Lan Weng

8 papers receiving 54 citations

Peers

Yi‐Lan Weng

MB

CR

ONCOL

PRM

GENET

Koji Arikawa Japan

Jonathan M. Goeldner Germany

Lena Nitsch Germany

Daqi Deng China

Judson Belmont United States

Mario Quintero-Aguilo Puerto Rico

Tommaso Mari Germany

Dina Ayupova United States

Luqi Jin China

Christian Lawerenz Germany

Koji Arikawa Japan

Yi‐Lan Weng

41 ×1.0

MB

16 ×0.9

CR

7 ×1.0

ONCOL

3 ×0.6

PRM

3 ×0.6

GENET

Citations per year, relative to Yi‐Lan Weng Yi‐Lan Weng (= 1×) peers Koji Arikawa

Countries citing papers authored by Yi‐Lan Weng

Since Specialization

Citations

This map shows the geographic impact of Yi‐Lan Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Lan Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Lan Weng more than expected).

Fields of papers citing papers by Yi‐Lan Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Lan Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Lan Weng. The network helps show where Yi‐Lan Weng may publish in the future.

Co-authorship network of co-authors of Yi‐Lan Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Lan Weng. A scholar is included among the top collaborators of Yi‐Lan Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Lan Weng. Yi‐Lan Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Cheng, Yating, et al.. (2025). Perfluoroalkyl substance pollutants disrupt microglia function and trigger transcriptional and epigenomic changes. Toxicology. 517. 154198–154198. 2 indexed citations

2.

Deng, Xiangyu, Lina Sun, Min Zhang, et al.. (2025). Biochemical profiling and structural basis of ADAR1-mediated RNA editing. Molecular Cell. 85(7). 1381–1394.e6. 1 indexed citations

3.

Lee, Sungmin, Clément Carré, André Fischer, et al.. (2023). Exploring the brain epitranscriptome: perspectives from the NSAS summit. Frontiers in Neuroscience. 17. 1291446–1291446. 2 indexed citations

4.

Hong, Wei, Yanding Zhao, Yi‐Lan Weng, & Chao Cheng. (2023). Random Forest model reveals the interaction between N6-methyladenosine modifications and RNA-binding proteins. iScience. 26(3). 106250–106250. 4 indexed citations

5.

Song, Hongjun, et al.. (2023). Epigenetic and epitranscriptomic regulation of axon regeneration. Molecular Psychiatry. 28(4). 1440–1450. 12 indexed citations

6.

Li, Shuang, Dawei Zou, Wenhao Chen, et al.. (2022). Ablation of BATF Alleviates Transplant Rejection via Abrogating the Effector Differentiation and Memory Responses of CD8+ T Cells. Frontiers in Immunology. 13. 882721–882721. 4 indexed citations

7.

Li, Shuang, Dawei Zou, Wenhao Chen, et al.. (2022). METTL3 inhibition reduces N⁶‐methyladenosine levels and prevents allogeneic CD4⁺ T‐cell responses. Immunology and Cell Biology. 100(9). 718–730. 17 indexed citations

8.

Cheng, Chao, Yanding Zhao, Evelien Schaafsma, Yi‐Lan Weng, & Christopher I. Amos. (2020). An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors. International Journal of Cancer. 147(9). 2621–2633. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact